๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comparison of high and low dose cyclophosphamide therapy in rheumatoid arthritis

โœ Scribed by H. James Williams; James C. Reading; John R. Ward; William M. O'Brien

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
626 KB
Volume
23
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Long-term cyclophosphamide therapy in rh
Long-term cyclophosphamide therapy in rheumatoid arthritis
โœ William M. Fosdick; James L. Parsons; Donald F. Hill ๐Ÿ“‚ Article ๐Ÿ“… 1968 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 594 KB

YTOTOXIC AGENTS have been used for C more than a decade in therapy of rheumatoid However, therapy with these agents has not been widely adopted. It has been restricted, in general, to short intensive courses for acutely ill, hospitalized patients as utilized in cancer chemotherapy. We have used Cyc

Bladder malignancy in a patient receivin
Bladder malignancy in a patient receiving low dose cyclophosphamide for treatment of rheumatoid arthritis
โœ Alan F. Ansher; John W. Melton III; Anthony J. Sliwinski ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 204 KB ๐Ÿ‘ 3 views

Cyclophosphamide treatment of malignant disease has been strongly associated with an increased incidence of bladder cancer. Recently there have been 3 papers reporting 4 cases of bladder cancer in patients treated with cyclophosphamide for benign disease (1-3). However, there is no increased inciden